Clinical Trials

Showing trials with last updates posted in 2023.

NCT04106167 | TERMINATED
20 participants

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Study Type:
OBSERVATIONAL
Last Updated:
2023-09-21
Start Date:
2019-06-11
Completion:
2023-08-11
Conditions
  • Advanced Solid Tumor
  • Lymphoma
  • Gastric Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • EGFR Positive Solid Tumor
  • HER2-positive Breast Cancer
  • Hepatocellular Carcinoma
  • Small-cell Lung Cancer
  • Renal Cell Carcinoma
  • Pancreas Cancer
  • Melanoma
  • NSCLC
  • Urothelial Carcinoma
  • Cervical Cancer
  • Microsatellite Instability
  • Merkel Cell Carcinoma
Interventions
  • GENETIC
No Results Yet
NCT03991104 | WITHDRAWN | PHASE1/PHASE2
0 participants

SOX-based CRT for Esophageal Cancer.

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-21
Start Date:
2019-05-01
Completion:
2021-12-31
Conditions
  • Esophageal Cancer
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT03960437 | COMPLETED | PHASE2
22 participants

The Effect of Etelcalcetide on CKD-MBD

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-21
Start Date:
2018-09-06
Completion:
2020-11-19
Conditions
  • Chronic Kidney Disease Mineral and Bone Disorder
  • Renal Osteodystrophy
  • Vascular Calcification
  • Hyperparathyroidism; Secondary, Renal
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page